Martin Hudson
About Martin Hudson
Martin Hudson, age 66, was appointed as an independent Class III director of SiriusPoint Ltd. effective September 1, 2025, with a term through the 2028 annual general meeting unless earlier vacated . He brings more than 40 years of international (re)insurance leadership across underwriting, risk management, governance, and executive roles, including service as independent non-executive director and chair across multiple companies in the sector . The Board determined he qualifies as independent under NYSE and SEC rules, and the Company entered into a standard director indemnification agreement with him .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Apollo Syndicate Management Ltd | Director | Feb 2018 – Feb 2025 | Governance oversight during remediation and growth phases |
| MS Amlin Underwriting Limited | Director | Mar 2020 – Aug 2023 | Oversight across underwriting risk and governance |
| Old Mutual Specialty Insurance | Director | Jan 2017 – Mar 2020 | Specialty insurance board governance |
| Travelers Insurance | Senior executive (prior career) | Not disclosed | Underwriting and leadership experience |
| Mitsui Sumitomo Insurance Group | Senior executive (prior career) | Not disclosed | Global operations leadership |
| Old Mutual Specialty Insurance | Senior executive (prior career) | Not disclosed | Executive management experience |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Liberty Mutual Managing Agency Ltd | Independent Non-Executive Director | Since Nov 2024 | UK Lloyd’s managing agency oversight |
| Liberty Mutual Insurance Europe SE | Independent Non-Executive Director | Since Nov 2024 | European insurance governance |
| Sirius International Managing Agency Ltd | Independent Non-Executive Chairman | Since Nov 2018 | Chair of Lloyd’s managing agency (Sirius International) |
| Novae Syndicates Ltd | Board service (prior) | Not disclosed | Lloyd’s market governance |
| SiriusPoint International Insurance Corporation (publ) | Board leadership (prior) | Not disclosed | International subsidiary leadership |
Board Governance
- Classification and term: Class III director through the 2028 AGM .
- Independence: Determined by the Board to be independent under NYSE/SEC rules .
- Committee assignments: None disclosed at appointment; Company stated committee assignment(s) will be disclosed in a subsequent Form 8-K .
- Indemnification: Standard indemnification agreement executed, consistent with other directors .
- Director compensation framework and ownership rules (policy-wide):
- Annual cash retainer for independent directors: $137,500; additional chair fees (Audit and Risk & Capital Management $35,000; Investment/Compensation/Governance $20,000; Non-Executive Chair $100,000; Lead Independent Director $50,000) .
- Annual restricted share grant for independent directors: $137,500 grant-date value; directors joining after the annual grant within the same calendar year receive 50% of the annual grant; awards typically vest at the next annual meeting .
- Share ownership guideline: Directors must own common shares valued at least three times the annual retainer within five years; hedging and pledging by directors are prohibited .
Fixed Compensation
| Component | Detail | Amount / Basis |
|---|---|---|
| Annual cash retainer | Independent director retainer | $137,500 per year |
| Committee chair fees | Audit; Risk & Capital Management | $35,000 per committee chair |
| Committee chair fees | Investment; Compensation; Governance & Nominating | $20,000 per committee chair |
| Board leadership | Non-Executive Chair | $100,000 |
| Board leadership | Lead Independent Director | $50,000 |
| Proration | Retainers paid quarterly; prorated for partial-year service | Policy states prorating for partial years |
Performance Compensation
| Component | Performance Metric | Vesting | Notes |
|---|---|---|---|
| Restricted shares (annual grant) | None (time-based, not performance-based) | Vest on the date of the next AGM following grant | Annual grant value $137,500; 50% grant for directors joining after annual grant within same calendar year |
| Stock options | Not used for directors | N/A | Policy does not include option grants for directors |
Other Directorships & Interlocks
| Company | Type | Role | Potential Interlock/Conflict |
|---|---|---|---|
| Liberty Mutual Managing Agency Ltd | Competitor in insurance/Lloyd’s | INED | Industry exposure; no Item 404(a) related-party transactions disclosed |
| Liberty Mutual Insurance Europe SE | Competitor in insurance | INED | Industry exposure; no Item 404(a) transactions disclosed |
| Sirius International Managing Agency Ltd | Group-related Lloyd’s agency | Independent Chairman | Group affiliate board; independence at SPNT affirmed; no Item 404(a) transactions |
| Apollo Syndicate Management Ltd | Insurance/Lloyd’s | Former Director | Prior oversight; no current conflicts disclosed |
| MS Amlin Underwriting Limited | Insurance/Lloyd’s | Former Director | Prior oversight; no current conflicts disclosed |
| Old Mutual Specialty Insurance | Insurance | Former Director | Prior oversight; no current conflicts disclosed |
The Company disclosed there are no arrangements or understandings pursuant to which he was named director, no family relationships, and no transactions requiring Item 404(a) disclosure .
Expertise & Qualifications
- 40+ years in underwriting leadership, risk management, governance, and executive management across US, UK, Europe, Canada, and Asia, including remediation and growth strategies .
- Board stewardship across Lloyd’s market entities and European insurance platforms; chair experience at Sirius International Managing Agency Ltd since 2018 .
- Independent non-executive oversight roles at Liberty Mutual entities since 2024 .
Equity Ownership
| Metric | Value | Notes |
|---|---|---|
| Total beneficial ownership (common shares) | 0 | Initial Form 3 filed Sept 9, 2025 states no securities beneficially owned |
| Ownership as % of shares outstanding | Not disclosed | No share count held; percent not provided |
| Vested vs. unvested shares | None disclosed | Initial holding zero; future grants per director policy |
| Pledging/Hedging | Prohibited | Company prohibits hedging and pledging by directors |
| Ownership guideline | 3x annual retainer within five years | Applies to all directors |
| Compliance status | Not applicable at appointment | Newly appointed; expected to build holdings via grants/cash purchases |
Insider Trades
| Filing | Date | Key Disclosure |
|---|---|---|
| Form 3 (Initial Statement of Beneficial Ownership) | Sept 9, 2025 | Reports no securities beneficially owned at appointment; filed by Attorney-in-Fact |
Governance Assessment
- Strengths: Independence affirmed; deep underwriting and governance experience; multi-market board stewardship; standard indemnification and adherence to robust governance policies (ownership guidelines; anti-hedging/pledging) .
- Committee participation: None at appointment; monitoring needed for eventual committee assignments (Audit/Risk/Compensation/Governance/Investment committees are composed of independent directors per policy) .
- Compensation alignment: Director pay structure is cash retainer plus time-based restricted shares, reinforcing long-term alignment; share ownership guideline (3x retainer over five years) enhances “skin in the game” .
- Related-party/Conflict check: Company disclosed no Item 404(a) transactions; no special arrangements leading to appointment; industry board roles noted but independence affirmed, reducing conflict risk .
RED FLAGS / Watch items
- Initial ownership at appointment was zero shares, creating an early alignment gap until grants or purchases accumulate; subject to 3x retainer guideline within five years .
- Committee roles pending; clarity on risk, audit, or investment oversight responsibilities will be important for evaluating board effectiveness .